Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 337

    1.

    Lack of evidence for recommended low-density lipoprotein cholesterol treatment targets.

    Modest GA.

    Ann Intern Med. 2007 Apr 17;146(8):614; author reply 614-5. No abstract available. PMID: 17438326 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Lack of evidence for recommended low-density lipoprotein cholesterol treatment targets.

    Ravnskov U.

    Ann Intern Med. 2007 Apr 17;146(8):614; author reply 614-5. No abstract available. PMID: 17438325 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Narrative review: lack of evidence for recommended low-density lipoprotein treatment targets: a solvable problem.

    Hayward RA, Hofer TP, Vijan S.

    Ann Intern Med. 2006 Oct 3;145(7):520-30. Review.PMID: 17015870 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Statins and aortic stenosis in the context of ratio of low- to high-density lipoprotein cholesterol.

    Yilmaz MB.

    J Am Coll Cardiol. 2007 Jul 17;50(3):289-90; author reply 290. Epub 2007 Jun 29. No abstract available. PMID: 17631225 [PubMed - indexed for MEDLINE]Related articles

    5.

    [Statin and absorption inhibitor work synergistically. More risk patient reach LDL cholesterol goal value]

    [No authors listed]

    MMW Fortschr Med. 2007 Apr 26;149(17):56-7. German. No abstract available. PMID: 17674912 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Ezetimib as combination partner in hypercholesteremia. Lowering LDL beyond the effect of statins]

    Sudhop T, von Bergmann K.

    MMW Fortschr Med. 2003 Apr 17;145(16):48-50. German. No abstract available. PMID: 14606402 [PubMed - indexed for MEDLINE]Related articles

    7.

    Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statins.

    Barter PJ, Rye KA.

    Circulation. 2006 Sep 19;114(12):1315-20; discussion 1320. No abstract available. PMID: 16982953 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    [Sequelae of the CARDS Study. LDL of 110 mg/dl still too high?]

    Klose G.

    MMW Fortschr Med. 2004 Jun 24;146(26):14. German. No abstract available. PMID: 15529683 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin.

    Gazi IF, Daskalopoulou SS, Nair DR, Mikhailidis DP.

    Curr Med Res Opin. 2007 Sep;23(9):2183-92.PMID: 17692154 [PubMed - indexed for MEDLINE]Related articles

    10.

    [Statins plus cholesterol resorption inhibitor. LDL goal values attainable]

    [No authors listed]

    MMW Fortschr Med. 2002 Sep 19;144(38):56. German. No abstract available. PMID: 12395708 [PubMed - indexed for MEDLINE]Related articles

    11.

    Low-density lipoprotein cholesterol reduction and prevention of cardiovascular disease.

    Stein EA.

    Mayo Clin Proc. 2009 Apr;84(4):307-9. No abstract available. PMID: 19339646 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Efficacy of rosuvastatin (5 mg and 10 mg) twice a week in patients intolerant to daily statins.

    Gadarla M, Kearns AK, Thompson PD.

    Am J Cardiol. 2008 Jun 15;101(12):1747-8. Epub 2008 Apr 11.PMID: 18549851 [PubMed - indexed for MEDLINE]Related articles

    13.

    [New studies of high dosage statins and fibrates. How is lipid lowering therapy changing? (interview by Dr. med. Dirk Einecke)]

    Klose G.

    MMW Fortschr Med. 2005 Dec 8;147(49-50):20. German. No abstract available. PMID: 16401005 [PubMed - indexed for MEDLINE]Related articles

    14.

    Aggressive low-density lipoprotein cholesterol lowering in secondary prevention of coronary heart disease.

    Clearfield M.

    Curr Atheroscler Rep. 2006 Jan;8(1):7-8. No abstract available. PMID: 16455005 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Prevention and treatment of coronary heart disease: lowering LDL, increasing HDL or monitoring both?]

    Windler E.

    Internist (Berl). 1996 Jun;37(6):643-6. German. No abstract available. PMID: 8768000 [PubMed - indexed for MEDLINE]Related articles

    16.

    High-dose statin therapy: benefits and safety in aggressive lipid lowering.

    Toth PP, Davidson MH.

    J Fam Pract. 2008 May;57(5 Suppl High-Dose):S29-36. Review. No abstract available. PMID: 18662521 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Lipid control in the double pack. Combined drugs to achieve the goal]

    [No authors listed]

    MMW Fortschr Med. 2002 Jun 6;144(23):53. German. No abstract available. PMID: 12119910 [PubMed - indexed for MEDLINE]Related articles

    18.

    [High dosage stain protects heart and brain from recurrence]

    [No authors listed]

    MMW Fortschr Med. 2008 Nov 27;150(48):118-9. German. No abstract available. PMID: 19125516 [PubMed - indexed for MEDLINE]Related articles

    19.

    Plant sterols as dietary adjuvants in the reduction of cardiovascular risk: theory and evidence.

    Patch CS, Tapsell LC, Williams PG, Gordon M.

    Vasc Health Risk Manag. 2006;2(2):157-62. Review.PMID: 17319460 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Comparison of low-density lipoprotein cholesterol lowering by pravastatin to <100 mg/dl versus >100 mg/dl on brachial artery vasoreactivity in patients with severe hypercholesterolemia and previous atherosclerotic events or diabetes mellitus.

    Lekakis JP, Papamichael CM, Barbaki P, Papaioannou TG, Stamatelopoulos KS, Dagre AG, Stamatelopoulos SF.

    Am J Cardiol. 2002 Apr 1;89(7):857-60. No abstract available. PMID: 11909575 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data